# Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients

> **NCT01157052** · PHASE1 · UNKNOWN · sponsor: **AHS Cancer Control Alberta** · enrollment: 15 (estimated)

## Conditions studied

- Neoplasms, Colorectal
- Colorectal Cancer
- Colorectal Carcinoma

## Interventions

- **OTHER:** (supplement) Calcium and Magnesium

## Key facts

- **NCT ID:** NCT01157052
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2014-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01157052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01157052, "Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01157052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*